FDA Best Audit Practices – Get Ready for the Inspection that is Coming


 Available : All Days  Presented By : Charles H. Paul
 Category : Pharmaceutical  Event Type : Recorded Webinar

For group or any booking support, contact:  cs@educationsgrow.com  + 1 (844) 240-7679 (US Toll Free)

Recording $199
Transcript $199
DVD $209
Flash Drive $229
Recording & Transcript $369

Description

This webinar will begin by discussing and emphasizing the importance of truthfulness to the process – truthfulness in performing the job on a daily basis, truthfulness in completing the regulatory documentation that is so much a part of our regulatory lives, and finally in the context of this webinar, truthfulness when interacting with FDA inspectors. A key component of this webinar is the discussion of the tricks and techniques that inspectors use to elicit information.

How you react and respond when they occur could impact your results. Other key communication skills will be presented in the context of the inspection and interpersonal exchanges between inspectors and company associates being questioned. We will complete the webinar by discussing how to handle, in the moment, adverse findings as they are identified by the inspector so as to not compound the issues and severity of the findings.

Areas Covered:-

  • Importance of truthfulness
  • Importance of knowledgeability and confidence
  • FDA Tricks to Elicit Information
  • Arguing and challenging
  • Behavior during the inspection
  • Importance and role of documentation
  • Effective communication skills
  • Being deceptive
  • Opinion versus fact
  • Phrases never to say
  • Handling adverse findings during the inspection

Background:-

The FDA has been increasing its surveillance of regulated industries. While it is a given that companies must meet their regulatory requirements, how company staff handle an audit and interact with FDA inspectors, can mean the difference between a successful and an unsuccessful FDA audit. The cost of an ineffective interaction can be staggering.

Why Should You Attend:-

If you are in any regulated business - pharmaceuticals, or medical devices, you will experience an inspection by the U.S. Food and Drug Administration (FDA). According to the Food, Drug, and Cosmetic Act, “Registered domestic drug establishments shall be inspected by the FDA at least once every two years.” Depending upon the inspection type and the circumstance, inspections may occur more frequently.

The outcome of those inspections can have a grave significant impact on your business even if you and your colleagues have done everything “right.” How you and others behave and interact with FDA inspectors can have an impact on the results reported. Interacting with inspectors is not a natural behavior, effective techniques must be learned and mastered if those inspections are to have positive outcomes.

Who Will Benefit:-

This is an all-inclusive webinar benefiting all individuals within the organization particularly those in positions of management and supervision. Vice Presidents, Directors, Associate Directors, Managers, and Supervisors in ALL functions will benefit from this organization. Significantly, compliance and regulatory who spearhead the inspections and are responsible for compliance readiness, as well as training that should be building on-going training around this subject should also be included.

Presented By : Charles H. Paul

Charles H. Paul is the President of C. H. Paul Consulting, Inc. – a regulatory, training, and technical documentation consulting firm. Charles has been a regulatory consultant to the life sciences industry for over 20 years and has published numerous white papers on the subject. The firm works with both domestic and international clients designing solutions for complex human performance and compliance-related problems.

Find More Pharmaceutical Webinars

Event Category Speaker Deatils
GMP Environmental Monitoring for Pharmaceutical Clean Rooms 2024 Pharmaceutical Roger Cowan View Event
The 6 Most Common Problems in FDA Software Validation and Verification Pharmaceutical David Nettleton View Event
21 CFR Part 11 and Annex 11 Compliance; Specifics Needed to Eliminate 483s When Using SaaS/Cloud Pharmaceutical David Nettleton View Event
Risk Management for AI in Medical Devices: Insights from FDA's Lifecycle Management Draft Guidance Pharmaceutical John E. Lincoln View Event
Data Integrity and Privacy: Compliance with 21 CFR Part 11, SaaS/Cloud, EU GDPR Pharmaceutical David Nettleton View Event

    Useful Links

  • Copyright 2025 educationsgrow . All Rights Reserved.

  • All Logos and Trade Marks on the website are property of their respective owner.